97 related articles for article (PubMed ID: 10023004)
1. Effects of quinolinone derivative, vesnarinone, in combination with irradiation on human lung cancer cell lines.
Fujita M; Tsuchida T; Fujita T; Higashino K
Oncol Rep; 1999; 6(2):353-7. PubMed ID: 10023004
[TBL] [Abstract][Full Text] [Related]
2. Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines.
Fujita M; Tsuchida T; Higashino K
Anticancer Drugs; 1999 Jan; 10(1):119-27. PubMed ID: 10194555
[TBL] [Abstract][Full Text] [Related]
3. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of cisplatin in combination with irradiation on lung tumor cell growth is due to induction of tumor cell apoptosis.
Fujita M; Fujita T; Kodama T; Tsuchida T; Higashino K
Int J Oncol; 2000 Aug; 17(2):393-7. PubMed ID: 10891552
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of anticancer effects of radiation and conventional anticancer agents by a quinolinone derivative, vesnarinone: studies on human gastric cancer tissue xenografts in nude mice.
Kawai K; Konishi Y; Izumi K; Sato M; Adachi M; Hozumi M
Anticancer Res; 1998; 18(1A):405-12. PubMed ID: 9568110
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
[TBL] [Abstract][Full Text] [Related]
8. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice.
Sato M; Harada K; Bando T; Shirakami T; Nakashiro K; Yoshida H; Nakai S; Kawai K; Adachi M
Cancer Lett; 1995 May; 91(1):1-9. PubMed ID: 7750082
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
11. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.
Kohara H; Tabata M; Kiura K; Ueoka H; Kawata K; Chikamori M; Aoe K; Chikamori K; Matsushita A; Harada M
Clin Cancer Res; 2002 Jan; 8(1):287-92. PubMed ID: 11801571
[TBL] [Abstract][Full Text] [Related]
13. Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice.
Honma Y; Yamamoto-Yamaguchi Y; Kanatani Y
Br J Cancer; 1999 Apr; 80(1-2):96-103. PubMed ID: 10389984
[TBL] [Abstract][Full Text] [Related]
14. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.
Matsumori A; Shioi T; Yamada T; Matsui S; Sasayama S
Circulation; 1994 Mar; 89(3):955-8. PubMed ID: 8124835
[TBL] [Abstract][Full Text] [Related]
15. The quinolinone derivative vesnarinone potentiates the cytotoxicity of doxorubicin in HL-60 leukemia cells.
Yamamoto M; Maehara Y; Sakaguchi Y; Kusumoto T; Baba H; Sugimachi K
Int J Oncol; 1997 Jan; 10(1):53-7. PubMed ID: 21533343
[TBL] [Abstract][Full Text] [Related]
16. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.
Matsui S; Matsumori A; Matoba Y; Uchida A; Sasayama S
J Clin Invest; 1994 Sep; 94(3):1212-7. PubMed ID: 8083362
[TBL] [Abstract][Full Text] [Related]
17. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
18. Vesnarinone: a differentiation-inducing anti-cancer drug.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T
Anticancer Drugs; 2003 Jul; 14(6):391-5. PubMed ID: 12853878
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line.
Shioi T; Matsumori A; Matsui S; Sasayama S
Life Sci; 1994; 54(1):PL11-6. PubMed ID: 8255163
[TBL] [Abstract][Full Text] [Related]
20. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 Jun; 164(11):5815-25. PubMed ID: 10820260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
